NEWS: Padres Pedal the Cause is coming back to Petco Park on April 9, 2022. Registration is open! Register Now

Curebound

The best ideas happen when the right people work together.

WORLD CLASS COLLABORATION

BACKGROUND

At Curebound, collaboration is everything.

Our funding model engineers collaboration across multiple disciplines and institutions. We provide early phase, follow-on and clinical trial funding to cross-institutional research teams that bring together physician scientists, clinical researchers, and basic-science researchers to work in partnership on a specific challenge in cancer research.

This combination of bringing clinical data to early, basic discovery research is unique to Curebound, and creates collaborations that otherwise would not exist.

Curebount

INSTITUTIONAL RESEARCH
PARTNERS

Curebound funds innovative, collaborative research between these six cancer research centers in San Diego.

undefined undefined
undefined undefined
undefined undefined
undefined undefined
undefined undefined
undefined undefined

TARGETED INVESTMENTS

INVESTMENT PILLARS &
AREAS OF OPPORTUNITY

Curebound considers applications for all types of cancer research projects and can curate opportunities for individuals to invest in specific areas of research. For philanthropists and organizations looking to direct funding toward exploration of a particular cancer type or treatment area, Curebound’s world class Scientific Advisory Board (SAB) will make discerning investments.

  • Prevention and diagnostic tools
  • Novel approaches and new therapeutic platforms
  • Immunotherapies and personalized vaccines
  • Addressing cancer disparities
  • Pediatric cancers
Curebound

CUREBOUND GRANTS

Curebound funds three types of cancer research grants:

Discovery Grants

• First time seed grants for high-risk, high-reward, collaborative, translational research. Ideas are innovative and in the early phases, where smaller grants of up to $250,000 can make a big impact in advancing research
• Discovery Grants are one-time grants and will be determined by the peer-review process established by Padres Pedal the Cause and implemented by the six beneficiary institutions.

Targeted Grants

• Larger and potentially multi-year gifts ranging from $250,000 to $1,000,000 that provide follow on funding to Discovery Grants that have met pre-determined goals e.g., demonstrated efficacy and have a clear plan of action e.g., to demonstrate innovation and differentiation with respect to standard-of-care and progress to meaningful clinical milestones, along with a well-supported budget.
• The SAB will also consider targeted funding for major public health and population studies as they align with Curebound investment pillars.

Cure Prizes

• Innovative, game changing, multidisciplinary projects that receive major funding ranging from $1,000,000 to $5,000,000, administered over multiple years.
• Cure Prize concepts will be determined collectively by the SAB and will seek to foster collaborations with and invoke matching funds from corporate industry partners, private investors, major federal grants and grants from other foundations.

RESEARCH PORTFOLIO

Curebound raises and invests strategic funding in translational cancer research projects aimed at accelerating new discoveries to clinical application. The full index of our research portfolio is available below.

Curebound

EXPLORATION

Curebound
Curebound

ACCELERATION

Curebound
Curebound

COLLABORATION

Curebound
Curebound

CURES